Susquehanna International Group
CLSD

Susquehanna International Group’s Clearside Biomedical CLSD Stock Holding History

Susquehanna International Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-807
Closed -$11.5K – 12576
2024
Q4 		$11.5K Sell
807
-1,233
-60% -$20.3K ﹤0.01% 11977
2024
Q3 		$38.9K Buy
+2,040
New +$34.8K ﹤0.01% 11469
2024
Q2 		– Sell
-947
Closed -$21.7K – 12147
2024
Q1 		$21.7K Sell
947
-1,473
-61% -$31.7K ﹤0.01% 11801
2023
Q4 		$42.5K Sell
2,420
-67
-3% -$955 ﹤0.01% 11776
2023
Q3 		$32.5K Sell
2,487
-1,233
-33% -$18.7K ﹤0.01% 11457
2023
Q2 		$62.5K Sell
3,720
-447
-11% -$7.7K ﹤0.01% 11235
2023
Q1 		$65K Buy
4,167
+2,774
+199% +$53.9K ﹤0.01% 11572
2022
Q4 		$23.4K Sell
1,393
-200
-13% -$3.6K ﹤0.01% 11705
2022
Q3 		$27K Sell
1,593
-1,034
-39% -$22.7K ﹤0.01% 12484
2022
Q2 		$58K Sell
2,627
-640
-20% -$15.5K ﹤0.01% 11884
2022
Q1 		$112K Sell
3,267
-6,460
-66% -$193K ﹤0.01% 11823
2021
Q4 		$401K Sell
9,727
-10,073
-51% -$652K ﹤0.01% 9767
2021
Q3 		$1.78M Buy
19,800
+4,927
+33% +$435K ﹤0.01% 6087
2021
Q2 		$1.09M Buy
14,873
+12,246
+466% +$569K ﹤0.01% 7538
2021
Q1 		$97K Buy
+2,627
New +$132K ﹤0.01% 11872
2019
Q1 		– Sell
-1,747
Closed -$28K – 8908
2018
Q4 		$28K Sell
1,747
-3,060
-64% -$144K ﹤0.01% 8629
2018
Q3 		$443K Buy
4,807
+1,294
+37% +$154K ﹤0.01% 6765
2018
Q2 		$563K Buy
3,513
+233
+7% +$39.3K ﹤0.01% 6553
2018
Q1 		$528K Buy
+3,280
New +$400K ﹤0.01% 6521

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CLSD Position: Q3 2025 in Review

Susquehanna International Group sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 5,975 shares — an estimated $71.7K sold.

Susquehanna International Group first reported a position in CLSD in Q4 2016 and held it in 23 quarters. The position peaked at $2.26M in Q3 2021. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Susquehanna International Group reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 5,975 Clearside Biomedical shares in Q3 2025, an estimated $71.7K.
  • Susquehanna International Group first reported a position in Clearside Biomedical in Q4 2016 and held it in 23 quarters.
  • Susquehanna International Group's Clearside Biomedical position peaked at $2.26M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.